WE ENVISION A WORLD WHERE WOMEN LIVE LONGER AND HEALTHIER LIVES BECAUSE OVARIAN CANCER CAN BE PREVENTED, CAUGHT EARLY, OR CURED.
Executive compensation, broken down
Form 990 · Part VII & Schedule J · 2 reported individuals · Filing year 2024
Percentile bands compare each position's total pay with the same role at Medical Research organizations nationwide.
- Base
- $162k
- Bonus
- —
- Other
- —
- Benefits
- $24k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
CEO Median to 75th percentile | $162k | — | — | $24k | $186k $198k |
Development Director (until 4/2024) Below 10th percentile | — | — | — | — | $35k $37k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with Seattle-Tacoma-Bellevue, WA metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 12 unpaid individuals.
Top pay as a share of expenses
In 2024, the highest total compensation at RIVKIN CENTER FOR OVARIAN CANCER equaled 11% of the organization's total expenses. The median for medical research organizations is 10%.
Based on 1,118 medical research organizations, each measured at its most recent filing year with reported expenses and compensation.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
Up 1%
from 2023
From $183k in 2023 to $186k in 2024.
Estimated with Seattle-Tacoma-Bellevue, WA metro-area CPI-U, restating filed pay into April 2026 dollars. A restatement of past pay, not current or projected pay.
Chief Executive Officer pay rose 1% from 2023 to 2024, while revenue rose 32%.
- Chief Development Officer pay fell 63% from 2023 to 2024.
Pay for the position itself, not any one person. The officeholder may have changed between 2023 and 2024.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Common questions about RIVKIN CENTER FOR OVARIAN CANCER
What does the Chief Executive Officer of RIVKIN CENTER FOR OVARIAN CANCER earn?
In 2024, the Chief Executive Officer of RIVKIN CENTER FOR OVARIAN CANCER received $185,682 in total compensation. This pay is above the median (the midpoint) for Chief Executive Officer roles among Medical Research organizations nationwide, within the top half of comparable filings. Based on IRS Form 990 data.
How does Chief Executive Officer pay at RIVKIN CENTER FOR OVARIAN CANCER compare with similar nonprofits?
Compared with the same role at Medical Research organizations nationwide, the 2024 pay of the Chief Executive Officer at RIVKIN CENTER FOR OVARIAN CANCER falls between the median and the 75th percentile. In 2024, the highest total compensation at RIVKIN CENTER FOR OVARIAN CANCER equaled 11% of the organization's total expenses. The median for medical research organizations is 10%.
What are RIVKIN CENTER FOR OVARIAN CANCER's revenue and expenses?
In 2024, RIVKIN CENTER FOR OVARIAN CANCER reported $1.7M in total revenue and $1.7M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read moreAre Nonprofit Salaries Public?
What IRS Form 990 discloses about executive compensation, who has to report it, and how to look it up.
Read more